Hutch News

The value of the combined hormone therapy trial, weighed in lives saved, billions of dollars

The value of the combined hormone therapy trial, weighed in lives saved, billions of dollars

The landmark study that prompted millions of women to stop taking combined hormone therapy resulted in $37.1 billion net economic return, thousands of lives saved, a new study finds
Hutch NewsMay 05, 2014
Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use

Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use

Fred Hutchinson Cancer Research Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers
News ReleasesJanuary 15, 2008